Moloney Securities Asset Management LLC Sells 290 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Moloney Securities Asset Management LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 12.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,110 shares of the financial services provider’s stock after selling 290 shares during the quarter. Moloney Securities Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $307,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in IBB. Highline Wealth Partners LLC bought a new stake in iShares Biotechnology ETF during the 3rd quarter valued at approximately $30,000. Bbjs Financial Advisors LLC bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $31,000. Voisard Asset Management Group Inc. bought a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $59,000. Chris Bulman Inc bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $64,000. Finally, Eastern Bank bought a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $65,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.1 %

Shares of IBB stock opened at $146.60 on Thursday. The stock has a 50 day moving average of $144.84 and a two-hundred day moving average of $140.88. iShares Biotechnology ETF has a 12 month low of $113.56 and a 12 month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.